Your search returned 5 results.

Results
	1.	No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder. [electronic resource] by Harfterkamp, Myriam van der Meer, Dennis van der Loo-Neus, Gigi Buitelaar, Jan K Minderaa, Ruud B Hoekstra, Pieter J Producer: 20160308 In: Journal of child and adolescent psychopharmacology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change. [electronic resource] by Harfterkamp, Myriam Buitelaar, Jan K Minderaa, Ruud B van de Loo-Neus, Gigi van der Gaag, Rutger-Jan Hoekstra, Pieter J Producer: 20150917 In: Journal of child and adolescent psychopharmacology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study. [electronic resource] by Harfterkamp, Myriam Buitelaar, Jan K Minderaa, Ruud B van de Loo-Neus, Gigi van der Gaag, Rutger-Jan Hoekstra, Pieter J Producer: 20131209 In: Journal of child and adolescent psychopharmacology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. [electronic resource] by Harfterkamp, Myriam van de Loo-Neus, Gigi Minderaa, Ruud B van der Gaag, Rutger-Jan Escobar, Rodrigo Schacht, Alexander Pamulapati, Sireesha Buitelaar, Jan K Hoekstra, Pieter J Producer: 20121204 In: Journal of the American Academy of Child and Adolescent Psychiatry vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms. [electronic resource] by van der Meer, Jolanda M J Harfterkamp, Myriam van de Loo-Neus, Gigi Althaus, Monika de Ruiter, Saskia W Donders, A Rogier T de Sonneville, Leo M J Buitelaar, Jan K Hoekstra, Pieter J Rommelse, Nanda N J Producer: 20140915 In: Journal of clinical psychopharmacology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)